USP5 and myeloproliferative neoplasm: Loaded with USP5-IN-1, the engineered exosomes demonstrated sustained drug release, enhanced Mut-MSC targeting, and potent induction of apoptosis, culminating in prolonged survival of MPN model mice (Scheme 1).